2019 International Congress

Monday, September 23, 2019

1:45pm-3:15pm

FUNCTIONAL MOTOR SYMPTOMS IN PARKINSON’S DISEASE, AND FUNCTIONAL PARKINSONISM: A SYSTEMATIC REVIEW

M. Ambar Akkaoui, P. Geoffroy, E. Roze, B. Degos, B. Garcin (Bobigny, France)

Functional (Psychogenic) Movement Disorders  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Functional stiff person like disorders: clinical features and red flags

B. Balint, A. Jha, M. Edwards, HM. Meinck, K. Bhatia (London, United Kingdom)

Functional (Psychogenic) Movement Disorders  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

GABA-A Receptor Positive Allosteric Modulators: Phase 2 Proof of Concept Studies of Brexanolone Injection and SAGE-217 in Essential Tremor

J. Paskavitz, A. Bullock, D. Nguyen, A. Smith, B. Farley, M. Quirk, I. Kaul, S. Li, A. Ellenbogen, C. Silber, J. Doherty, H. Colquhoun, S. Kanes (Cambridge, MA, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Gait in Spinocerebellar Ataxia Type12 (SCA-12)

M. Narang, A. Srivastava, R. Aggarwal, R. Rajan, M. Faruq, M. Srivastava (Delhi, India)

Ataxia  ·  Les Muses, Level 3

1:45pm-3:15pm

GBA and ATP13A mutation and PD: clinical phenotype, eye movements and pathogenic implications

GM. Riboldi, J. Martone, J. Rucker, JR. Rizzo, T. Hudson, W. Dauer, S. Frucht (New York, NY, USA)

Genetics  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

GBA mutation: Linking Parkinson’s and Gaucher’s Diseases

C. Sarabia-Tapia, S. Lopez-Alamillo, N. Monroy-Jaramillo, D. Davila-Ortiz, M. Rodriguez-Violante, A. Cervantes-Arriaga (Mexico City, Mexico)

Genetics  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

GBA p.Glu326Lys substitution increases the risk to develop Parkinson’s disease; is it enough to affect disease phenotype?

O. Goldstein, M. Gana- Weisz, D. Cohen-Avinoam, A. Bar-Shira, A. Thaler, T. Shiner, A. Mirelman, N. Giladi, A. Orr-Urtreger (Tel Aviv, Israel)

Genetics  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

GBA1 biomarkers in longitudinal CSF: GCase, Sphingolipids and alpha-synuclein

S. Lerche, C. Schulte, G. Machetanz, I. Wurster, B. Röben, M. Zimmermann, C. Deuschle, A. Hauser, I. Liepelt-Scarfone, J. Böhringer, I. Krägeloh-Mann, I. Lachmann, W. Maetzler, T. Gasser, M. Mielke, D. Berg, K. Brockmann (Tuebingen, Germany)

Genetics  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Gender gap in scientific granting competitions in movement disorders – insights from a national Canadian funding agency

S. Appel-Cresswell, P. Blanchet, J. Wysocki, R. Postuma (Vancouver, BC, Canada)

Other  ·  Agora 2 West, Level 2

1:45pm-3:15pm

Gene Expression Profiling of depression in Huntington’s disease

G. Colpo, N. Rocha, E. Furr Stimming, A. Lucio (Houston, TX, USA)

Huntington’s Disease  ·  Agora 3 West, Level 3